AzTrials
AzTrials

Atrophic MaxillaNCT07014085

Prospective Study of Bone Augmentation With Lateral Sinus Lift and Osseointegration of Dental Implants

A study testing "Histomorphometric Evaluation of Bone Augmentation Using Xenografts Versus Autologous Bone Grafts in Dental Implant Patients: A Comparative Clinical Study in people with Atrophic Maxilla and Partial Edentulism, run by Maria H. Pham.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

By using a split-mouth model in the maxilla, lateral sinus lift procedures will be performed using xenograft on one side vs autologous bone augmentation and PRF membranes on the other side. The purpose is to qualify and verify each step of this study to ensure the reliability and validity of the results. Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Atrophic Maxilla, Partial Edentulism
What is being tested?
"Histomorphometric Evaluation of Bone Augmentation Using Xenografts Versus Autologous Bone Grafts in Dental Implant Patients: A Comparative Clinical Study
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
1 Jul 2025to 31 Dec 2035
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Partially edentulous jaws in the lateral segment with 2 or more nearby lost teeth in the posterior upper jaw (maxilla), where the vertical height is a minimum of 2mm
  • absence of marginal periodontal disease
  • patients in American Society of Anesthesiologists ASA group 1-2 over 18 years.

Who cannot join

  • ASA group 3 and above
  • ongoing infection
  • bruxism or abnormal habit
  • poor oral hygiene
  • medical conditions that may compromise healing (uncontrolled diabetes etc)
  • treatments that interfere with healing in the jaw bone (bisphosphonate, steroid therapy) radiotherapy or chemotherapy within the last 5 years
Show all 10Show fewer
  • alcohol or substance abuse
  • heavy smoking
  • pregnancy
  • desire not to participate

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Maria H Pham, DDS, PhD contact

+4740044139

hmnpham@uio.no

About this study

Official title: Histomorphometric Evaluation of Bone Augmentation Using Xenograft vs Autologous Bone Graft With Dental Implants. A Comparative Clinical Study.

By using a split-mouth model in the maxilla, lateral sinus lift procedures will be performed using xenograft on one side vs autologous bone augmentation and PRF membranes on the other side. The purpose is to qualify and verify each step of this study to ensure the reliability and validity of the results.

Read the detailed description

Title: "Histomorphometric Evaluation of Bone Augmentation Using Xenografts Versus Autologous Bone Grafts in Dental Implant Patients: A Comparative Clinical Study"

Objective: This study aims to compare and analyse the effectiveness of xenograft and autologous bone grafts in bone augmentation procedures for patients requiring dental implants in a clinical setting. By comparing the outcomes of bone augmentation using xenografts and autologous bone grafts, this study aims to develop treatment protocols prioritising reduced invasiveness and enhanced efficiency. Understanding which grafting material yields better osseointegration can lead to more streamlined procedures, benefiting clinicians and patients. Furthermore, we aim to assess their efficacy in achieving optimal outcomes in bone augmentation procedures by implants and biomaterials in the study. The unique aspect of this study is the use of a split-mouth model and advanced digital technologies for data collection and analysis, which can provide more accurate and comprehensive insights into the comparative effectiveness of xenografts and autologous bone grafts.

Methodology: Utilizing a split-mouth model in the maxilla, external lateral sinus lift procedures will be performed using xenograft on one side and autologous bone augmentation and PRF membranes on the other side of the patients. A total of 20 patients will be included, with 40 implants placed. As part of the study methodology, digital technologies will be utilised for data collection and analysis. This includes digital imaging techniques for pre-operative assessment and post-operative evaluation of bone augmentation outcomes. By leveraging digital technologies, we aim to enhance the accuracy and efficiency of data collection, enabling comprehensive analysis of the comparative effectiveness of xenografts and autologous bone grafts. Rest assured, every step of this study has been meticulously planned and executed to ensure the reliability and validity of the results.

Rationale: The success of dental implants, particularly in cases of partial or total edentulism with jaw atrophy, hinges on achieving primary stability and osseointegration. Bone augmentation using either xenograft or autologous bone has been commonly employed for such treatments. However, there is an urgent need for further clinical research to evaluate the osseointegration outcomes between xenografts and autologous bone in bone augmentation procedures. The comparative analysis of xenografts and autologous bone grafts will provide crucial insights into the prevention and management of complications such as infection, graft failure, and resorption associated with bone augmentation procedures. By identifying which grafting material leads to fewer biological and technical complications, clinicians can tailor treatment protocols to minimize adverse events and maximize patient safety. This aligns with Straumann's commitment to continuously improving treatment protocols to ensure the long-term success of dental implants and restorative procedures.

Significance: With the ageing population and increasing prevalence of partial or total edentulism, the challenges associated with dental implants will continue to rise. Bone augmentation using xenografts or autologous grafts can potentially enhance implant stability and success rates, improving patients' quality of life and mental well-being. This study aims to contribute valuable insights into treatment protocols that can positively impact patient outcomes.

Being tested
"Histomorphometric Evaluation of Bone Augmentation Using Xenografts Versus Autologous Bone Grafts in Dental Implant Patients: A Comparative Clinical Study
Keywords
bone augmentation, dento alveolar surgery, oral surgery, comparative prospective study, clinical study, lateral sinus lift, dental implants, osseointegration, prf, autologus graft, xenograft, atrophic maxilla
Medical subject headings
Atrophic Maxilla

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "Histomorphometric Evaluation of Bone Augmentation Using Xenografts Versus Autologous Bone Grafts in Dental Implant Patients: A Comparative Clinical StudyProcedure or surgery

    Split mouth comparative clinical prospective study xenograft vs autologous graft

Study groups in NCT07014085
Study groupRoleWhat they receive
5 years follow up studyOtherosseointegration 5 year follow up
Receives: Procedure: "Histomorphometric Evaluation of Bone Augmentation Using Xenografts Versus Autologous Bone Grafts in Dental Implant Patients: A Comparative Clinical Study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effect of autogenous bone graft vs xenograft

    Quality measurements of bone augmentation with autologous and xenograft with histology and radiological examination

    Measured: Up to two years

  2. Evaluation of Bone Augmentation Using Xenografts Versus Autologous Bone Grafts Dental Implant Patients: A Comparative Clinical Study

    Measurement of survival rates and osseointegration of dental implants with questionnaires and radiology examination

    Measured: Up til 2 years

Secondary outcomes (1)
  1. A prospective clinical study 3 years of follow up: Bone graft with dental implants

    Survival rate and measurements with dental implants with questionnaires and radiology examination

    Measured: Up to 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2025
  2. Study start1 Jul 2025 (estimated)
  3. Primary completion31 Dec 2035 (estimated)
  4. Study completion31 Dec 2035 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
split mouth, using the participant as a control vs test group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07014085
Sponsor's protocol ID
Oral surgery and Oral medicine
Status last verified
Jun 2025
First submitted
12 May 2025
Last updated
24 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing "Histomorphometric Evaluation of Bone Augmentation Using Xenografts Versus Autologous Bone Grafts in Dental Implant Patients: A Comparative Clinical Study in people with Atrophic Maxilla and Partial Edentulism, run by Maria H. Pham.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Maria H Pham, DDS, PhD (+4740044139, hmnpham@uio.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effect of autogenous bone graft vs xenograft (time frame: Up to two years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in